The study of diagnosis and treatment of facial palsy

JRCT ID: jRCT1031190235

Registered date:02/03/2020

Basic Information

• Recruitment status: Recruiting
• Health condition(s) or Problem(s) studied: Facial palsy caused by viral peripheral neuritis
• Date of first enrollment: 30/03/2020
• Target sample size: 564
• Study type: Interventional

Intervention(s)

Randomized controlled trial of steroid dose

A group. start dose of prednisolone is 60mg. Tapering off in 10 days.
B group. start dose of prednisolone is 120mg. Tapering off in 10 days.

Outcome(s)

• Primary Outcome: Recovery rate of facial palsy.

Secondary Outcome

Improvement rate of facial palsy
Incidence of adverse event
Developing diagnostic method of causing virus
Evaluation about quality of life relating facial palsy

Key inclusion & exclusion criteria

• Age minimum: >= 20age old
• Age maximum: Not applicable
• Gender: Both

Include criteria

1. Facial palsy patients 7 days or less after onset
2. Moderate or severe facial palsy patients(Yanagihara score is 18 and under)
3. Obtained written informed consent

• Exclude criteria: Patients who are contraindications or relative contraindications to administration of test drug, prednisolone.

Related Information

• Primary Sponsor: Wasano Koichiro
• Source(s) of Monetary Support: National Hospital Organization,Donation from the participant of the 'Dissemination of evidence-based treatment for facial palsy' project (https://academist-cf.com/projects/219) which was held in academic cloud funding, Academist.